EMD.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 02:10):

Stats
Today's Volume	529 273
Average Volume	238 261
Market Cap	19.80M
EPS	$0 ( 2024-02-25 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.270
ATR14	$0 (0.00%)

Emerald Clinics Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Emerald Clinics Ltd Financials

Annual	2023
Revenue:	$1.59M
Gross Profit:	$-3.32M (-208.56 %)
EPS:	$-0.0177

Q2	2024
Revenue:	$1.09M
Gross Profit:	$-1.59M (-146.03 %)
EPS:	$-0.0324

Q4	2023
Revenue:	$860 318
Gross Profit:	$-1.39M (-161.00 %)
EPS:	$-0.00370

Q3	2022
Revenue:	$430 159
Gross Profit:	$-89 324.00 (-20.77 %)
EPS:	$-0.00200

Financial Reports:

No articles found.

Emerald Clinics Ltd

Emyria Limited, a clinical-stage biotech company, engages in the development of treatments for unmet medical needs. The company develops cannabinoid-based medicines, as well as MDMA drug discovery program. Its drug development program includes EMD-RX5 for treatment of psychological distress and irritable bowel syndrome; and EMD-RX7 for multiple medical conditions. The company was formerly known as Emerald Clinics Limited and changed its name to Emyria Limited in September 2020. Emyria Limited was founded in 2018 and is headquartered in Leederville, Australia.